BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30283890)

  • 1. Flare-Up After Maxillofacial Surgery in a Patient With Fibrodysplasia Ossificans Progressiva: An [
    Eekhoff EMW; Netelenbos JC; de Graaf P; Hoebink M; Bravenboer N; Micha D; Pals G; de Vries TJ; Lammertsma AA; Raijmakers PG; van Es RJ
    JBMR Plus; 2018 Jan; 2(1):55-58. PubMed ID: 30283890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [18F]NaF PET/CT scan as an early marker of heterotopic ossification in fibrodysplasia ossificans progressiva.
    Eekhoff EMW; Botman E; Coen Netelenbos J; de Graaf P; Bravenboer N; Micha D; Pals G; de Vries TJ; Schoenmaker T; Hoebink M; Lammertsma AA; Raijmakers PGHM
    Bone; 2018 Apr; 109():143-146. PubMed ID: 28826841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of heterotopic bone in fibrodysplasia ossificans progressiva: An [
    Botman E; Raijmakers PGHM; Yaqub M; Teunissen B; Netelenbos C; Lubbers W; Schwarte LA; Micha D; Bravenboer N; Schoenmaker T; de Vries TJ; Pals G; Smit JM; Koolwijk P; Trotter DG; Lammertsma AA; Eekhoff EMW
    Bone; 2019 Jul; 124():1-6. PubMed ID: 30858149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of Magnetic Resonance Imaging in Fibrodysplasia Ossificans Progressiva.
    Botman E; Teunissen BP; Raijmakers P; de Graaf P; Yaqub M; Treurniet S; Schoenmaker T; Bravenboer N; Micha D; Pals G; Bökenkamp A; Netelenbos JC; Lammertsma AA; Eekhoff EM
    JBMR Plus; 2020 Jun; 4(6):e10363. PubMed ID: 32537549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy in Fibrodysplasia Ossificans Progressiva: A Case Report and Systematic Review of the Literature.
    Botman E; Netelenbos JC; Rustemeyer T; Schoonmade LJ; Nieuwenhuijzen JA; Teunissen BP; Visser M; Raijmakers P; Lammertsma AA; Dahele M; Eekhoff M
    Front Endocrinol (Lausanne); 2020; 11():6. PubMed ID: 32117050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restricted Mandibular Movement Attributed to Ossification of Mandibular Depressors and Medial Pterygoid Muscles in Patients With Fibrodysplasia Ossificans Progressiva: A Report of 3 Cases.
    Okuno T; Suzuki H; Inoue A; Kusukawa J
    J Oral Maxillofac Surg; 2017 Sep; 75(9):1891-1898. PubMed ID: 28390760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent.
    Upadhyay J; Xie L; Huang L; Das N; Stewart RC; Lyon MC; Palmer K; Rajamani S; Graul C; Lobo M; Wellman TJ; Soares EJ; Silva MD; Hesterman J; Wang L; Wen X; Qian X; Nannuru K; Idone V; Murphy AJ; Economides AN; Hatsell SJ
    J Bone Miner Res; 2017 Dec; 32(12):2489-2499. PubMed ID: 28782882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When Limb Surgery Has Become the Only Life-Saving Therapy in FOP: A Case Report and Systematic Review of the Literature.
    Botman E; Treurniet S; Lubbers WD; Schwarte LA; Schober PR; Sabelis L; Peters EJG; van Schie A; de Vries R; Grunwald Z; Smilde BJ; Nieuwenhuijzen JA; Visser M; Micha D; Bravenboer N; Coen Netelenbos J; Teunissen BP; de Graaf P; Raijmakers PGHM; Smit JM; Eekhoff EMW
    Front Endocrinol (Lausanne); 2020; 11():570. PubMed ID: 32973683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-γ agonist palovarotene: a case report.
    Singh S; Kidane J; Wentworth KL; Motamedi D; Morshed S; Schober AE; Hsiao EC
    BMC Musculoskelet Disord; 2020 Apr; 21(1):204. PubMed ID: 32245464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives.
    Smilde BJ; Botman E; de Ruiter RD; Smit JM; Teunissen BP; Lubbers WD; Schwarte LA; Schober P; Eekhoff EMW
    Orthop Res Rev; 2022; 14():113-120. PubMed ID: 35480068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Evaluation of Pain, Flare-Up, and Emotional Health in Fibrodysplasia Ossificans Progressiva: Analyses of the International FOP Registry.
    Peng K; Cheung K; Lee A; Sieberg C; Borsook D; Upadhyay J
    JBMR Plus; 2019 Aug; 3(8):e10181. PubMed ID: 31485551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes.
    Pignolo RJ; Baujat G; Brown MA; De Cunto C; Di Rocco M; Hsiao EC; Keen R; Al Mukaddam M; Sang KLQ; Wilson A; White B; Grogan DR; Kaplan FS
    Orphanet J Rare Dis; 2019 May; 14(1):98. PubMed ID: 31053156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial.
    Pignolo RJ; Baujat G; Hsiao EC; Keen R; Wilson A; Packman J; Strahs AL; Grogan DR; Kaplan FS
    J Bone Miner Res; 2022 Oct; 37(10):1891-1902. PubMed ID: 35854638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of Jaw Movement in Fibrodysplasia Ossificans Progressiva: A Review.
    Schoenmaker T; Dahou Bouchankouk A; Özkan S; Gilijamse M; Bouvy-Berends E; Netelenbos C; Lobbezoo F; Eekhoff EMW; de Vries TJ
    Front Med (Lausanne); 2022; 9():852678. PubMed ID: 35391888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of New Heterotopic Ossification (HO) in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP).
    Pignolo RJ; Hsiao EC; Al Mukaddam M; Baujat G; Berglund SK; Brown MA; Cheung AM; De Cunto C; Delai P; Haga N; Kannu P; Keen R; Le Quan Sang KH; Mancilla EE; Marino R; Strahs A; Kaplan FS
    J Bone Miner Res; 2023 Mar; 38(3):381-394. PubMed ID: 36583535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analog Method for Radiographic Assessment of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva.
    Rajapakse CS; Lindborg C; Wang H; Newman BT; Kobe EA; Chang G; Shore EM; Kaplan FS; Pignolo RJ
    Acad Radiol; 2017 Mar; 24(3):321-327. PubMed ID: 27989444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable.
    Al Mukaddam M; Rajapakse CS; Pignolo RJ; Kaplan FS; Smith SE
    Bone; 2018 Apr; 109():147-152. PubMed ID: 28822792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrodysplasia ossificans progressiva (FOP): report of a case with extra-articular ankylosis of the mandible.
    Kriegbaum RK; Hillerup S
    J Craniomaxillofac Surg; 2013 Dec; 41(8):856-60. PubMed ID: 23510591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-COVID-19 exacerbation of fibrodysplasia ossificans progressiva with multiple flare-ups and extensive heterotopic ossification in a 45-year-old female patient.
    Grgurevic L; Novak R; Hrkac S; Salai G; Grazio S
    Rheumatol Int; 2021 Aug; 41(8):1495-1501. PubMed ID: 34110466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unresolving trismus following third molar surgery: Report of a case of fibrodysplasia ossificans progressiva with review of literature.
    Rajanikanth BR; Prasad K; Vineeth K; Sonale SMN; Al-Kubra K
    Cranio; 2018 Sep; 36(5):341-349. PubMed ID: 28797219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.